114 related articles for article (PubMed ID: 3624050)
1. Using measured dose distribution data of the Fletcher-Suit-Delclos colpostat in brachytherapy treatment planning.
Yorke ED; Schell MC; Gaskill JW; Ling CC
Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1413-9. PubMed ID: 3624050
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.
Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS
Med Phys; 2005 Jul; 32(7):2288-94. PubMed ID: 16121584
[TBL] [Abstract][Full Text] [Related]
3. Design of a plastic minicolpostat applicator with shields.
Weeks KJ; Montana GS; Bentel GC
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1045-52. PubMed ID: 1917601
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo dose calculations for a new ovoid shield system for carcinoma of the uterine cervix.
Weeks KJ
Med Phys; 1998 Dec; 25(12):2288-92. PubMed ID: 9874820
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
Zakariaee SS; Mahdavi SR
Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
[TBL] [Abstract][Full Text] [Related]
6. In-vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix.
Alecu R; Alecu M
Med Phys; 1999 May; 26(5):768-70. PubMed ID: 10360540
[TBL] [Abstract][Full Text] [Related]
7. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
Markman J; Williamson JF; Dempsey JF; Low DA
Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study.
Price MJ; Gifford KA; Horton J; Lawyer A; Eifel P; Mourtada F
Phys Med Biol; 2006 Aug; 51(16):4083-94. PubMed ID: 16885626
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of the Fletcher family of gynecologic colpostats 1950-1980.
Haas JS; Dean RD; Mansfield CM
Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1317-21. PubMed ID: 4008289
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder.
Steggerda MJ; Moonen LM; Damen EM; Lebesque JV
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):237-45. PubMed ID: 9300759
[TBL] [Abstract][Full Text] [Related]
11. Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy.
Hira M; Podgorsak MB; Jaggernauth W; Malhotra HK
Brachytherapy; 2011; 10(3):232-41. PubMed ID: 20932810
[TBL] [Abstract][Full Text] [Related]
12. Fletcher-Suit-Delclos gynecologic applicator: evaluation of a new instrument.
Haas JS; Dean RD; Mansfield CM
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):763-8. PubMed ID: 6853274
[TBL] [Abstract][Full Text] [Related]
13. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional applicator system for carcinoma of the uterine cervix.
Weeks KJ; Montana GS
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):455-63. PubMed ID: 9069321
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric evaluation of a newly designed low dose rate brachytherapy applicator for treatment of cervical cancer with extension into the lower vagina.
Baker C; Dini SA; Kudrimoti M; Awan SB; Meigooni AS
J Appl Clin Med Phys; 2007 Apr; 8(2):37-46. PubMed ID: 17592462
[TBL] [Abstract][Full Text] [Related]
16. Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry.
Decker WE; Erickson B; Albano K; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):561-7. PubMed ID: 11380246
[TBL] [Abstract][Full Text] [Related]
17. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.
Gifford KA; Horton JL; Pelloski CE; Jhingran A; Court LE; Mourtada F; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):615-21. PubMed ID: 16168853
[TBL] [Abstract][Full Text] [Related]
18. Influence of different Fletcher-Suit applicator geometries on sagittal dose distribution.
Palvolgyi J
Phys Med; 2010 Jan; 26(1):49-54. PubMed ID: 19386528
[TBL] [Abstract][Full Text] [Related]
19. On the determination of the effective transmission factor for stainless steel ovoid shielding segments and estimation of their shielding efficacy for the clinical situation.
Verellen D; De Neve W; Van den Heuvel F; Storme G; Coen V; Coghe M
Med Phys; 1994 Nov; 21(11):1677-84. PubMed ID: 7891627
[TBL] [Abstract][Full Text] [Related]
20. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
